No CrossRef data available.
Article contents
Cholinergic treatment across the spectrum: therapeutic trends in mild to severe dementia
Published online by Cambridge University Press: 01 September 2006
Abstract
The field of Alzheimer's disease (AD) research is in transition. Advances in our knowledge of AD pathology are translating into improved understanding of pharmacological agents that may have benefits across the spectrum of the illness. A major focus of current research is the potential ability of cholinergic therapy to enhance function and quality of life in all patients affected by AD, from the mildest to the most advanced stages.
- Type
- Guest Editorial
- Information
- Copyright
- International Psychogeriatric Association 2006